Nephrology

In the general population, African Americans die at earlier ages than whites, but among patients on dialysis, African Americans live longer than whites.…

Researchers have discovered that the desirable range for HbA1c levels is higher for diabetic patients on dialysis than guidelines recommend for the general diabetic population….

Women with type 2 diabetes are more likely to have risk factors for chronic kidney disease than men, which may also put them at risk for poorer outcomes.…

In patients with CKD, coronary artery calcification predicted the risk of CVD events, especially in those with no history of it.…

Intensive therapy for type 1 diabetes mellitus lowers the long-term risk for impaired glomerular filtration rate (GFR).…

Poor glycemic control, whether too high or too low, is associated with decreased survival in diabetic patients on hemodialysis….

Metabolic syndrome (MetS) and its components are linked to the development of chronic kidney disease (CKD), according to the results of a systematic review and meta-analysis.…

Patients approaching end-stage renal disease are increasingly receiving the nephrology consultation they need before initiating kidney dialysis; however, the trend has surprisingly not resulted in an improvement in mortality rates, according to a new study.…

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 9 to 6 against recommending the approval of the first in class novel antidiabetic agent dapagliflozin, largely because of fears that the product may cause breast and bladder cancer.… The EMDAC panel was also concerned about a lack of pharmacokinetic …

Conventional glucose control monitoring methods may not be as meaningful in diabetes patients with end-stage renal disease, researchers found. Patients on dialysis will normally show a lower A1c than they actually have, giving patients and physicians a false sense of security.… The Gold standard long-term glucose monitoring test for patients …